Comprehensive pharmacogenetic profiling of the epidermal growth factor receptor pathway for biomarkers of response to, and toxicity from, cetuximab-Reference-Cited by-同舟云学术

Comprehensive pharmacogenetic profiling of the epidermal growth factor receptor pathway for biomarkers of response to, and toxicity from, cetuximab

Published:2017-03-10 Issue:8 Volume:54 Page:567-571
ISSN:0022-2593
Container-title:Journal of Medical Genetics
language:en
Short-container-title:J Med Genet

Author:

Madi Ayman,Fisher David,Maughan Timothy S,Colley James P,Meade Angela M,Tejpar Sabine,Van den Bosch Ben,Maynard Julie,Humphreys Vikki,Wasan Harpreet,Adams Richard A,Idziaszczyk Shelley,Harris Rebecca,Kaplan Richard S,Cheadle Jeremy P

Funder

Cancer Research Wales

Tenovus

Merck Serono

Wales Gene Park

Cancer Research UK

Publisher

BMJ

Subject

Genetics (clinical),Genetics

Reference20 articles.

1. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial;Maughan;Lancet,2002

2. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

3. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

4. Cetuximab for the treatment of colorectal cancer;Jonker;N Engl J Med,2007

5. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC;Pharmaceutics;2022-11-15

2. Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers;Expert Review of Clinical Pharmacology;2022-06-03

3. Genetic Markers of the Host to Predict the Efficacy of Colorectal Cancer Targeted Therapy;Current Medicinal Chemistry;2020-07-22

4. Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy;European Journal of Cancer;2018-10